📣 VC round data is live. Check it out!

Alibaba Health Valuation Multiples

Discover Alibaba Health's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Nykaa, Zalando, Vipshop, Meesho and more.

Alibaba Health Overview

About Alibaba Health

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.


Founded

1998

HQ

China

Employees

1.4K

Financials (LTM)

Revenue: $5B
EBITDA: $296M

EV

$6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Alibaba Health Financials

Alibaba Health reported last 12-month revenue of $5B and EBITDA of $296M.

In the same LTM period, Alibaba Health generated $1B in gross profit, $296M in EBITDA, and $287M in net income.

Revenue (LTM)


Alibaba Health P&L

In the most recent fiscal year, Alibaba Health reported revenue of $5B and EBITDA of $239M.

Alibaba Health is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 5%, and net margin of 5%.

See analyst estimates for Alibaba Health
LTMLast FY202320242025202620272028
Revenue$5B$5B$4B$4B$5B
Gross Profit$1B$1B$864M$1B$1B
Gross Margin24%24%22%24%24%
EBITDA$296M$239M$134M$217M$277M
EBITDA Margin6%5%3%5%6%
EBIT Margin6%5%2%5%6%
Net Profit$287M$212M$118M$191M$266M
Net Margin6%5%3%4%5%

Financial data powered by Morningstar, Inc.

Alibaba Health Stock Performance

Alibaba Health has current market cap of $8B, and enterprise value of $6B.

Market Cap Evolution


Alibaba Health's stock price is $0.48.

Alibaba Health share price increased by 3.0% in the last 30 days, and decreased by 21.1% in the last year.

Alibaba Health has an EPS (earnings per share) of $0.01.

See more trading valuation data for Alibaba Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6B$8B3.0%3.0%-19.8%-21.1%$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Alibaba Health Valuation Multiples

Alibaba Health trades at 1.2x EV/Revenue multiple, and 21.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Alibaba Health

EV / Revenue (LTM)


Alibaba Health Financial Valuation Multiples

As of June 2, 2026, Alibaba Health has market cap of $8B and EV of $6B.

Alibaba Health has a P/E ratio of 26.8x.

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.4x1.6x1.4x1.3x
EV/EBITDA21.0x25.9x46.4x28.6x22.4x
EV/EBIT20.6x26.6x76.2x30.8x22.1x
EV/Gross Profit5.0x5.6x7.2x6.0x5.3x
P/E26.8x36.4x65.4x40.2x28.9x
EV/FCF31.2x30.5x49.1x32.4x35.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Alibaba Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Alibaba Health Margins & Growth Rates

Alibaba Health grew revenue by 11% and EBITDA by 21% in the last fiscal year.

In the most recent fiscal year, Alibaba Health reported gross margin of 24%, EBITDA margin of 5%, and net margin of 5%.

See estimated margins and future growth rates for Alibaba Health

Alibaba Health Margins

Last FY202420252026202720282029
Gross Margin24%24%24%24%
EBITDA Margin5%5%6%6%
EBIT Margin5%5%6%6%
Net Margin5%4%5%5%
FCF Margin4%4%4%6%

Alibaba Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth11%10%12%13%
Gross Profit Growth10%21%13%11%
EBITDA Growth21%62%28%14%
EBIT Growth27%147%39%13%
Net Profit Growth34%63%39%10%
FCF Growth(18%)52%(8%)76%

Data powered by FactSet, Inc. and Morningstar, Inc.

Alibaba Health Operational KPIs

Alibaba Health's revenue per employee in the last FY averaged $3.3M, while opex per employee averaged $0.6M for the same period.

Alibaba Health's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alibaba Health's Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Alibaba Health
LTMLast FY202320242025202620272028
Rule of 4019%19%---
Bessemer Rule of X38%38%---
Revenue per Employee-$3.3M---
Opex per Employee-$0.6M---
S&M Expenses to Revenue7%7%7%7%7%
G&A Expenses to Revenue1%1%1%1%1%
R&D Expenses to Revenue2%2%3%2%2%
Opex to Revenue-19%20%19%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Alibaba Health Competitors

Alibaba Health competitors include Nykaa, Zalando, Vipshop, Meesho, Droga Raia, Chewy, Lenskart, Vishal Mega Mart, Wayfair and MatsukiyoCocokara.

Most Alibaba Health public comparables operate across Pharmacies, Vertical E-commerce, Consumer E-commerce and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Nykaa7.7x7.4x100.1x95.3x
Zalando0.4x0.4x6.1x5.7x
Vipshop0.2x0.2x2.2x2.3x
Meesho6.1x5.8x(67.2x)(60.4x)
Droga Raia0.9x0.9x11.5x11.4x
Chewy0.7x0.7x12.2x11.1x
Lenskart10.0x9.5x46.6x47.1x
Vishal Mega Mart4.3x4.2x28.3x28.9x

This data is available for Pro users. Sign up to see all Alibaba Health competitors and their valuation data.

Start Free Trial

Investments by Alibaba Health

Alibaba Health has invested in 6 companies to date.

Latest investment by Alibaba Health was on July 31st 2023. Alibaba Health invested in Atantares in their $14M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Alibaba Health

Atantares
Landing Medical High Technology
Gene+
Guizhou Ensure Chain Pharmacy Company
Description
Atantares is a semiconductor technology firm advancing biomedicine through silicon-based microfluidics. The company leverages chip miniaturization and integration to deliver ultra-high throughput and sensitivity for applications in medical diagnostics, synthetic biology, and DNA data storage. Headquartered in Shenzhen, China, Atantares addresses demands in healthcare and biotech by providing scalable platforms that handle complex fluidic processes at microscopic scales.
Landing Medical High Technology is a med-tech firm creating AI-driven diagnostic technology for cervical cancer screening. Its Landing Shares platform processes colposcopy images to detect precancerous lesions with high sensitivity. The company operates from China, supplying tools to women's health clinics across Asia.
Gene+ is a China-based precision oncology company offering genetic testing for cancer prevention and treatment. The firm conducts gene panel sequencing in partnership with over 100 hospitals nationwide. Its diagnostics cover tumor profiling, companion diagnostics, and monitoring services. Gene+ operates advanced sequencing laboratories to support oncologists with actionable genomic insights.
Guizhou Ensure Chain Pharmacy Company is a Guiyang-headquartered retail chain operating over 300 pharmacies across Guizhou province. The firm sells prescription drugs, over-the-counter medicines, and health products through urban and rural outlets. Guizhou Ensure Chain provides online ordering via WeChat and delivery services, partnering with provincial hospitals for medication distribution since its 2005 founding.
HQ CountryChinaChinaChinaChina
HQ City
Shanghai
Wuhan
Beijing
Guizhou
Deal Date31 Jul 202310 Nov 202122 Jul 202121 Aug 2018
RoundSeedSeries DSeries CStrategic investment
Raised$14M$50M$116M$126M
InvestorsAlibaba Health; Asia Green Fund; Fosun Health Capital; Frees Fund; NeuX Capital; Next Capital; Qiming Venture PartnersAlibaba Health; Ether CapitalAlibaba Health; Baidu Ventures; CCB Capital; CCB International; Fortune Capital; Fortune Venture Capital; GGV Capital; Harvest Capital; Jinmao Capital; Junci Investment; Sharewin InvestmentAlibaba Health
Valuationundisclosedundisclosedundisclosed$421M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Alibaba Health investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Alibaba Health

When was Alibaba Health founded?Alibaba Health was founded in 1998.
Where is Alibaba Health headquartered?Alibaba Health is headquartered in China.
How many employees does Alibaba Health have?As of today, Alibaba Health has over 1K employees.
Who is the CEO of Alibaba Health?Alibaba Health's CEO is Difan Shen.
Is Alibaba Health publicly listed?Yes, Alibaba Health is a public company listed on HKEX.
What is the stock symbol of Alibaba Health?Alibaba Health trades under 00241 ticker.
When did Alibaba Health go public?Alibaba Health went public in 1972.
Who are competitors of Alibaba Health?Alibaba Health main competitors include Nykaa, Zalando, Vipshop, Meesho, Droga Raia, Chewy, Lenskart, Vishal Mega Mart, Wayfair, MatsukiyoCocokara.
What is the current market cap of Alibaba Health?Alibaba Health's current market cap is $8B.
What is the current revenue of Alibaba Health?Alibaba Health's last 12 months revenue is $5B.
What is the current revenue growth of Alibaba Health?Alibaba Health revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Alibaba Health?Current revenue multiple of Alibaba Health is 1.2x.
What is the current EBITDA of Alibaba Health?Alibaba Health's last 12 months EBITDA is $296M.
What is Alibaba Health's EBITDA margin?Alibaba Health's last 12 months EBITDA margin is 6%.
What is the current EV/EBITDA multiple of Alibaba Health?Current EBITDA multiple of Alibaba Health is 21.0x.
What is the current FCF of Alibaba Health?Alibaba Health's last 12 months FCF is $199M.
What is Alibaba Health's FCF margin?Alibaba Health's last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Alibaba Health?Current FCF multiple of Alibaba Health is 31.2x.
How many companies Alibaba Health has acquired to date?Alibaba Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Alibaba Health has invested to date?As of June 2026, Alibaba Health has invested in 6 companies.
What was the last Alibaba Health investment?On 31st July 2023 Alibaba Health invested in Atantares, participating in a $14M Seed round, alongside Asia Green Fund, Fosun Health Capital, Frees Fund, NeuX Capital, Next Capital, and Qiming Venture Partners.
In what companies Alibaba Health invested in?Alibaba Health invested in Guizhou Ensure Chain Pharmacy Company, One Tree Pharmaceutical, Gene+, Landing Medical High Technology, Wanliyun Medical Information Technology, and Atantares.

See public comps similar to Alibaba Health

Lists including Alibaba Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial